Dow up 0.64% Nasdaq up 0.68%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
 Dow up 0.64% Nasdaq up 0.68%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

Quote Results

Add Quotes

SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
Sep 18 95.88 +0.25 +0.26% 95.61 96.65 1,691,558 1,756,290 37.98B Sparkline Chart Chart, News, Stats, Options, Board
Sep 18 23.97 -0.11 -0.46% 23.91 24.17 4,297,879 2,896,330 21.18B Sparkline Chart Chart, News, Stats, Options, Board
Sep 18 48.38 -0.28 -0.58% 48.20 48.85 144,196 169,786 3.07B Sparkline Chart Chart, News, Stats, Options, Board
Sep 18 57.14 +0.03 +0.05% 57.10 57.70 370,642 418,258 3.46B Sparkline Chart Chart, News, Stats, Options, Board
Sep 18 73.95 -0.16 -0.22% 73.79 74.41 1,098,226 881,486 8.62B Sparkline Chart Chart, News, Stats, Options, Board
Sep 18 61.03 -0.83 -1.34% 60.75 61.83 2,582,481 1,888,820 17.96B Sparkline Chart Chart, News, Stats, Options, Board
Sep 18 112.06 +1.11 +1.00% 111.00 112.48 436,257 394,870 8.35B Sparkline Chart Chart, News, Stats, Options, Board
Sep 18 105.93 +2.09 +2.01% 104.10 106.50 16,347,901 13,227,800 160.13B Sparkline Chart Chart, News, Stats, Options, Board
No such ticker symbol: CTRX.TOTry Symbol Lookup
Sep 18 102.80 -0.04 -0.04% 102.66 102.98 3,725,405 2,155,520 11.44B Sparkline Chart Chart, News, Stats, Options, Board
{"s" : "amt,ggp,slgn,clh,jbht,vtr,arg,gild,trw","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

Quotes delayed, except where indicated otherwise.

Recent News

day and time symbols news headline and source
Thursday September 18, 2014
VENTAS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online04:08pm EDT
Gilead Down on Weak Simtuzumab Data and Sovaldi News Zacks04:02pm EDT
Air Products Hits New High After Reorganizing at Investor's Business Daily01:38pm EDT
ZF net debt seen at $11 bln after TRW deal -source Reuters11:26am EDT
2 Columbia Growth Funds Notch Impressive Three-Month Performance Benzinga10:52am EDT
Gilead Sciences: Failed Trial Always a 'Long Shot' at Barrons.com10:14am EDT
Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% Zacks08:35am EDT
Ventas Prices Cdn$400 Million of 3.00% Senior Notes Due 2019 and Cdn$250 Million of 4.125% Senior Notes Due 2024 Business Wire08:34am EDT
Wednesday September 17, 2014
[$$] ZF, TRW Aim to Provide Bundles of High-Tech Parts at The Wall Street Journal11:20pm EDT
ZF’s Sommer Sees More Acquisitions Beyond TRW Purchase at Bloomberg11:12pm EDT
CVS: One In 12 Hepatitis C Patients Not Adhering To $1,000/Day Pill at Forbes10:22pm EDT
Gilead's Sovaldi Usage Fades As Hep-C Patients Await Rivals Investor's Business Daily06:25pm EDT
TRW Falls on News of Buyout Deal by ZF Friedrichshafen Zacks05:05pm EDT
Ventas Elects Former White House Domestic Policy Director Melody Barnes to Board of Directors Business Wire04:33pm EDT
TRW AUTOMOTIVE HOLDINGS CORP. ALERT: Levi & Korsinsky, LLP Announces Investigation of TRW Automotive Holdings Corp. and Its Board of Directors In Connection With the Sale of the Company to ZF Friedrichshafen AG -- TRW PR Newswire03:52pm EDT
Regeneron Gets Breakthrough Therapy Status for Eylea Zacks03:30pm EDT
Video: Gilead Stock Falls On These Drug Setbacks at Investor's Business Daily12:52pm EDT
Gilead Sciences: What to Make of Its Latest Failure? at Barrons.com11:20am EDT
[$$] Gilead Cancer Treatment Fails at The Wall Street Journal06:58am EDT
6:01 am Gilead Sciences announces data from Phase 2 study of Simtuzumab for previously untreated pancreatic cancer; the addition of simtuzumab (200 mg or 700 mg) to gemcitabine did not significantly increase progression-free survival compar Briefing.com06:01am EDT
Gilead Announces Data From Phase 2 Study of Simtuzumab for Previously Untreated Pancreatic Cancer Business Wire06:00am EDT
Tuesday September 16, 2014
Gilead Sciences Investor's Business Daily06:53pm EDT
Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs05:21pm EDT
Stocks Rise Ahead Of Fed, Led By Biotech, Chip Names at Investor's Business Daily05:01pm EDT
VENTAS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online04:33pm EDT